In the past decade, both the number of such studies and their sample sizes have increased dramatically. Recent GWAS of height and body mass index (BMI) in ~250,000 European participants have led to the discovery of ~700 and ~100 nearly independent SNPs associated with these traits, respectively. Here we combine summary statistics from those two studies with GWAS of height and BMI performed in ~450,000 UK Biobank participants of European ancestry.
from the uniform null distribution (height: λ GC =3.2; BMI: λ GC =2.5), suggesting polygenicity and possibly population stratification. The mean of association chisquare statistics is ~7.2 for height and ~3.4 for BMI, consistent with a randomly chosen SNP, on average, being associated with height at p<0.007 and with BMI at p<0.07. We performed LD score regression (LDSC) 17, 18 to quantify the contribution of population stratification to our results. We found that LDSC intercept (I LDSC ) was inflated for both height (I LDSC =1.48, s.e. 0.1) and BMI (I LDSC =1.08, s.e. 0.02), suggesting a significant contribution of population stratification. However, although classically used, this statistic may not accurately reflect the contribution of population stratification as it can rise above 1 with increased sample size and heritability 13 . In contrast, the attenuation ratio statistic R PS = (I LDSC -1)/(mean of association chisquare statistics -1), which does not have these limitations, was shown to yield a better quantification of population stratification 13 . We found for height and BMI that R PS equals 0.06 (s.e. 0.01) and 0.03 (s.e. 0.01), respectively, which implies that polygenicity is the main driver of the observed inflation of test statistics. We also used the LDSC methodology to estimate the genetic correlation between summary statistics from GIANT height and that from UKB, as well as between summary statistics from GIANT BMI and that from UKB. We found a genetic correlation (r g ) of 0.96 (s.e. 0.01) for height and of 0.95 (s.e. 0.01) for BMI, highlighting a strong genetic homogeneity between UKB and previous meta-analyses, and thus confirming the validity of using a fixed-effect meta-analysis. Also, this analysis implied significant overlap of ~59,000 participants between UKB and GIANT height (bivariate LDSC intercept: 0.17; s.e. 0.05), but not between UKB and GIANT BMI (bivariate LDSC intercept: 0.01; s.e. 0.01). The latter observation is surprising given that the vast majority of cohorts included in GIANT height are also included in GIANT BMI .
Analogous to the univariate case, we observed in simulations that large sample sizes and heritabilities can inflate the bivariate LDSC intercept even in the absence of sample overlap (Supplementary Note; Fig S1) . We therefore conclude that sample overlap is likely negligible between UKB and GIANT height as it is between UKB and GIANT BMI .
Using an approximate conditional and joint multiple-SNP (COJO) analysis implemented in GCTA 19 that takes into account linkage disequilibrium (LD) between SNPs at a given locus, we identified 3,290 and 716 SNPs (COJO p<1×10 -8 ; Table 1) associated with height and BMI respectively. This more conservative significance threshold was chosen from the recommendations of a previous study 20 which showed that type I error was not properly controlled at the classical 5×10 -8 thresold when using SNPs imputed to the Haplotype Reference Consortium or 1,000 genomes imputation reference panels. Compared to GIANT height and GIANT BMI , our findings represent a ~5 and ~7-fold increase of the number of GWAS signals associated with height and BMI respectively. The 3,290 height-associated SNPs consist of 2,388 primary associations and 902 secondary signals, i.e. genome-wide significant (GWS) in GCTA-COJO analysis only. These 3,290 SNPs clustered in 712 genomic loci (locus is defined as in ref. 5 as one or multiple jointly associated SNPs located within a 1-Mb window), including 409 loci not previously detected in GIANT height . For BMI, the 716 SNPs identified consist of 450 primary associations and 266 secondary signals, clustered in 416 genomic loci including 353 loci not previously detected in GIANT BMI . We found that the average number of height and BMI associated SNPs per locus is 4.6 and 1.7 respectively, but also observed a large variability of that number (standard deviation: ~6 SNPs/locus for height loci and ~2 SNPs/locus for BMI loci). We found one locus on chromosome 12q23.2 (chr12:102,229,631-103,278,745; genome build hg19) that concentrates up to 19 jointly significant signals for height within ~1.05 Mb. That locus contains the IGF1 gene which was previously identified in GIANT height . Note however that only 2 independent associations within that locus were reported at that time, indicating that larger GWAS improves the characterisation of the allelic heterogeneity of genomic loci.
We assessed the replicability of these associations by estimating the regression slope of SNP effect size estimated in an independent sample onto the SNP effect sizes (corrected for winnner's curse effects 21, 22 ) from our meta-analyses, using 8,552 unrelated individuals from the Health and Retirement Study (HRS). A similar approach to quantify replicability was been applied in Turley et al. (2017) 23 . We found significant regression slopes for height (0.90; s.e. 0.02) and BMI (0.91; s.e. 0.04), both close to one and therefore suggesting a high level of replicability of our findings ( Fig. 2) .
Predictive power of polygenic scores
We estimated in HRS participants using the GCTA-GREML approach 9,10,19 that GWS SNPs explain 24.6% (s.e. 1.3%) and 5.0% (s.e. 0.7%) of the variance of height and BMI, respectively, adjusting for 20 PCs for both traits. This represents a ~1.5 and ~2.6-fold improvement in comparison with previous meta-analyses ( Fig. 3a-b ). For each HRS participant, we also calculated genetic predictors of height and BMI from GWS SNPs as the sum of trait increasing alleles at these loci, weighted by their estimated effect sizes. We found the squared correlation between predicted height and actual height to be ~19.7% and between predicted BMI and actual BMI to be ~4.1% ( Fig. 3c-d) . We performed additional prediction analyses using SNPs with significance p-values larger than 10 -8 . We performed GCTA-COJO analyses for height and BMI and analysed SNPs with significance p-value below 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 and 10 -8 . We therefore calculated 6 genetic predictors for each trait and quantified in HRS participants the fraction of trait variance explained by SNPs contributing to these predictors as well as their predictive capacity ( Fig. 3) . As reported in Wood et al. (2014) , we found that including SNPs beyond GWS increases prediction accuracy and variance explained ( Fig. 3) in both traits. For height, the variance explained increased from ~24.6% using 3,290 GWS SNPs to ~34.7% (s.e. 1.9%) using ~15,000 SNP with p<0.001. The prediction R 2 also increased from ~19.7% to ~24.4%. For BMI, the variance explained using ~9000 SNPs selected in the COJO analysis at p<0.001 is ~10.3% (s.e. 1.4%) and the corresponding prediction R 2 is ~8.6%, which is twice the prediction accuracy obtained using GWS loci only.
Gene prioritization
We next attempted to identify genes whose expression levels could potentially mediate the association between SNPs and height or between SNPs and BMI. For this purpose, we performed a summary-data based Mendelian randomization (SMR) analysis 24 . This method aims at testing the association between gene expression (in a particular tissue) and a trait using the top associated expression quantitative trait loci (eQTL) as a genetic instrument. For this analysis, which only requires GWAS summary statistics, we used the publicly available GTEx-v7 database containing eQTLs for multiple genes in multiple tissues 25 . We identified 610 ( that of height or BMI. Significant SMR test indicates evidence of causality or pleiotropy but also the possibility that SNPs controlling gene expression are in linkage disequilibrium with those associated with the traits. These two situations can be disentangled using the HEIDI (HEterogeneity In Dependent Instrument) test implemented in the SMR software. The number of genes reported above corresponds to genes already filtered on statistical evidence supporting pleiotropy or causality rather than linkage between variants controlling gene expression and variants controlling height or BMI (P HEIDI > 0.05). We found that >95% (597/610=~98% for height and 105/110=~95% for BMI) of height-and BMI-associated genes identified via the SMR analysis show consistent direction of effects across multiple tissues. As an example, we found that higher expression of PIGP across 23 tissues is associated with increased height; and that higher expression of HSD17B12 across 41 tissues is associated with decreased BMI. We then quantified the enrichment of the genes identified via SMR and HEIDI tests, into biological pathways. Altogether, we found 
Mediation through epigenetic mechanisms
We performed another SMR and HEIDI analysis to now prioritise CpG dinucleotides which methylation levels mediate the association between SNPs and height or BMI.
For this analysis, we used publicly available methylation QTL (mQTL) from the McRae et al. (2017) study 26 in peripheral blood. We identified 775 and 176 ( Table 1) DNA methylation sites showing pleiotropic associations with height and BMI respectively. Among all CpG sites identified, we found that increased DNA methylation at cg19825988 (within the ZBTB38 gene) has the largest positive mediation effect on height (~0.4 SD for 100% methylation; p SMR = 3.5×10 -9 ). The ZBTB38 gene, located within a previously identified GWAS locus (GIANT height ), encodes a zinc finger transcriptional activator that binds methylated DNA. This gene was also detected in our first SMR analysis (using gene expression) described above.
For BMI, the largest effect of DNA methylation was observed at cg03755535 (within the first exon of the CAMKV gene); where decreased DNA methylation correlates positively with increased BMI (-0.14 SD for 100% methylation; p SMR = 4.9×10 -8 ).
This gene was not detected in our first SMR analysis but is located within a previously identified GWAS locus.
Discussion
We have presented here the results of the meta-analysis of a single large study, the UK Biobank, with previously published GWAS of height and BMI. We found that the number of genomic loci associated with height and BMI is disproportionately increased compared to previously published GWAS, and that this increase correlates with increased trait variance explained and improved accuracy of genetic predictors from SNPs at these loci. In addition, we have shown that large GWAS enhance the power of integrative analyses such as pathway enrichment and summary-data based Mendelian randomization to unveil relevant genes to be prioritized for further functional studies.
Our analyses revealed a number challenges to address when dealing with very large GWAS. One of these challenges relates to conclusions from LDSC, a method now routinely used for quality control (detection of confounding effects) and inference of genetic parameters like heritability and genetic correlation. Following the recent study by Loh et al. (2018) , which pointed out a number of caveats relative to the interpretation of the univariate LDSC intercept as an indicator of confounding due to population stratification or other artefacts, we have shown here that caution must also be applied when interpreting the intercept of the bivariate LDSC. These two problems, which are directly related to each other, both illustrate how the effect of very subtle population stratification can be dramatically magnified when sample sizes are large. We recall here the suprising observation that, despite considering the same sets of cohorts, the conclusions about sample overlap from bivariate LDSC intercept were radically different between GWAS of height and GWAS of BMI. Similar to the univariate case, we recommend the use of an attenuation ratio statistic to measure how much of the inflation in the bivariate LDSC intercept is explained by correlated population stratification or sample overlap.
Another challenge faced in this study relates to the over-correction of population stratification. In general, setting up expectations with respect to how many GWAS signals can be reasonably detected or how much variance can be explained from SNPs identified in a GWAS of a given sample has always been a difficult question. In particular, the detection of "too many" GWAS signals has often been a concern in the GWAS literature and seen as an indication of potentially uncorrected population stratification. With very large datasets like UKB, some of these questions can be now addressed. We observed that the number of variants and fraction of variance explained by GWAS hits identified from random subsets of UKB of the same size as GIANT height or GIANT BMI was larger than that discovered in those studies ( Table 2) .
Multiple reasons could explain these differences, as for example genetic and phenotypic heterogeneity between cohorts included in these two meta-analyses 27 .
Nonetheless, we argue that methods classically used to correct for the effects of population stratification may have removed a substantial amount of the signal to be detected. To further illustrate this point, we re-analysed the data from Locke et al.
(2015). Our new analysis consisted of deflating the genomic control (GC) corrected standard errors of estimated SNP effects with a factor equal to the square-root of the LDSC intercept. This transformation constrains the LDSC intercept to be 1 but is less conservative than the double GC correction (i.e. GC correction in each cohort included in the meta-analysis, and GC correction applied to the outcome of the metaanalysis) used in Locke et al. (2015) . We found in this secondary analysis that the number of GWAS signals (at p<10 -8 ) increased from 77 to 210 (~3-fold increase), the variance explained increased from ~1.8% to ~2.8% and the prediction accuracy of genetic predictors using those SNPs from 1.8% to 2.4% (Fig. S2) . This observation demonstrates that a correction based on LDSC intercept performs better than GC correction but still remains imperfect, since we know that LDSC intercept also increases with sample size. New methods must therefore be developed in order to maximize the potential of discovery of forthcoming GWAS of ever-larger sample sizes.
In summary, our study confirms the potential for new discoveries of large genomewide association studies and announces a gargantuan number of new discoveries for 1 0 the next iteration of meta-analyses of the GIANT consortium based on sample sizes in the order of 1 million and more.
Online methods

UK Biobank analyses
Sample selection
We analysed data from 488,377 genotyped participants of the UK Biobank (UKB).
We restricted the analysis to 456,426 participants of European ancestry. Ancestry was inferred using a two-stage approach. The first step consisted of projecting each study participant onto the first two genotypic principal components (PC) calculated from HapMap 3 SNPs genotyped in 2,504 participants of 1,000 genomes project 28 . We then used five super-populations (European, African, East-Asian, South-Asian and Admixed) as reference and assigned each participant to the closest population.
Distance was defined as the posterior probability under a bivariate Gaussian distribution of each participant to belong to one of the five super-populations. This method generalizes the k-means method and takes into account the orientation of the reference cluster to improve the clustering. Vectors of means and 2×2 variancecovariance matrices were calculated for each super-population, using a uniform prior.
SNP selection
We 
Replication
We used genotypes imputed to the 1,000 genomes reference panel and phenotypes (height and body mass index) from 8,552 unrelated (GRM < 0.05) participants of the Health and Retirement Study (HRS) to assess the replicability of SNPs found to be associatd with height and BMI. We also used these data to assess the variance explained by different sets of SNPs as well as the out-of-sample prediction accuracy of genetic predictors using these sets of SNPs. Analyses were restriced to 2,484,330
HapMap 2 SNPs with an imputation quality score >0.3, a minor allele frequency >0.01 and a p-value from Hardy-Weinberg equilibrium test >10 -6 .
Given that replication of individual SNP is not feasible because of the limited sample size of our replication cohort, we assessed the overall replicability of SNP-traits associations using the regression slope of estimated SNP effects from the replication study onto estimated SNP effect sizes from the discovery study. Values of this slope of ~1 indicate good replicability of GWAS findings. SNPs brought forward for replication are subjected to the winner's curse effect and their effect sizes are biased 21, 22 . We therefore used the correction proposed by Zhong & Prentice (2018) (ref. 20 ) before estimating the replication slope. ata_files. Before meta-analysis with UKB, we filtered out SNPs which reported pairs of alleles did not match the pairs of alleles in the HRS and UKB and also which had reported allele frequency too different (absolute difference > 0.15) from that calculated using unrelated participants of HRS. Fixed-effect inverse variance weighted meta-analysis was performed using the software METAL 16 .
Summary statistics QC and meta-analyses
Linkage disequilibrium score regression
We performed linkage disequilibrium (LD) score regression to quantify the level of confounding in GWAS due to population stratification as well as quantifying the sample overlap between cohorts involved in previous meta-analyses and the UK 
Summary of results
Supplementary Note
We performed a simulation to quantify the inflation of the bivariate LD score regression (LDSC) intercept created when the sample size of each GWAS and the heritability are large. We used for our simulations genotypes at 1,123,348 HapMap 3
SNPs (Online methods) from 348,502 unrelated (genetic relationship < 0.05) participants of the UK Biobank (UKB) with European ancestry (Online methods). To mimic independent GWAS, we randomly split our dataset in two sub-samples of equal size (N 1 = N 2 = 174,251), and simulated 9 traits with the same 10,000 causal variants (randomly sampled among HapMap 3 SNPs) and with an heritability varying from 0.1, 0.2,…, up to 0.9. Each trait was simulated with same SNPs effect sizes in each sub-sample so that the genetic correlation is expected to be 1. We then performed a GWAS of these nine simulated traits in each sub-sample separately, then used GWAS summary statistics to perform a bivariate LD score regression. LD score regression was performed using the LDSC softare v1.0.0 and using LD scores from European samples of the 1,000 genomes reference panel. We present the results our this simulation in Fig. S1 . Overall, we found when the heritability is larger than 0.5, samples between the two subsets. We also observed an inflation of the univariate LDSC intecept (Fig. S1, panel b) , but as mentioned previously, this observation is expected under the theory derived in
